| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$47 |
Agreement for combined Anteo X product in the USA
|
21 Jul 2025 9:20AM |
$0.013 |
$0.018 |
risen by
34.62%
|
|
ADO - Price-sensitive ASX Announcement
Full Release
Key Points
- AnteoTech Limited has entered into a distribution agreement with ADO for Anteo X in the USA.
- ADO receives exclusive rights for Anteo X distribution in certain market segments and to specified customers.
- Anteo X is a newly developed product by AnteoTech targeting the US market.
- The agreement outlines terms, responsibilities, and exclusivity clauses.
- The partnership aims to accelerate Anteo X market adoption and revenue growth in the United States.
- Details provided on commercial structure and anticipated sales strategy.
- The collaboration is expected to enhance AnteoTech’s US market presence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amaero Ltd (3DA) ORDINARY FULLY PAID |
Industrials |
$332 |
Quarterly Activities Report and Appendix 4C
|
21 Jul 2025 9:19AM |
$0.445 |
$0.480 |
risen by
7.87%
|
|
3DA - Price-sensitive ASX Announcement
Full Release
Key Points
- Amaero advanced the construction and equipment procurement for its titanium powder manufacturing facility in Tennessee.
- Discussions with potential customers and partners for offtake agreements and collaborations are ongoing.
- Product qualification, regulatory approvals, and operational preparedness were key focus areas for the quarter.
- The company reported operational and capital investment-related cash outflows in the period.
- Amaero maintained sufficient cash reserves at the end of the quarter.
- The Appendix 4C contains a detailed breakdown of cash flows for operating, investing, and financing activities.
- Amaero’s strategic objectives include completing facility construction, securing customer agreements, and preparing for production commencement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$5 |
Change of Director's Interest Notice PM
|
21 Jul 2025 9:19AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$4 |
Tambourah Drilling Update RC Program Extended
|
21 Jul 2025 9:18AM |
$0.022 |
$0.022 |
fallen by
0%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$2 |
TMB: Tambourah Drilling Update RC Program Extended
|
21 Jul 2025 9:18AM |
$0.019 |
$0.019 |
fallen by
0%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$137 |
Notification of buy-back - BCN
|
21 Jul 2025 9:17AM |
$1.205 |
$1.295 |
risen by
7.47%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$137 |
Beacon Announces On Market Share Buy-Back
|
21 Jul 2025 9:17AM |
$1.205 |
$1.295 |
risen by
7.47%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited announced an on-market share buy-back.
- Up to 10% of shares may be purchased over a 12-month period.
- The buy-back aims to improve capital efficiency and deliver shareholder value.
- The Board believes the share price undervalues the company’s assets and prospects.
- Funding will come from existing cash reserves.
- Buy-back execution depends on market conditions and share price.
- The Board retains discretion over the number of shares bought back.
- The buy-back will comply with ASX Listing Rules and the Corporations Act.
- No guarantee that the entire 10% will be purchased.
- There will be no effect on company control or ASX listing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,696 |
Trading Halt
|
21 Jul 2025 9:17AM |
$5.300 |
$5.300 |
fallen by
0%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX Limited requested a trading halt on June 18, 2024.
- The trading halt is related to a forthcoming capital raising announcement.
- ASX granted the trading halt to IPX securities.
- The halt will remain until June 20, 2024, or until the announcement is released.
- The halt was requested to ensure an orderly market for the company's securities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$5 |
Change of Director's Interest Notice TG
|
21 Jul 2025 9:17AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| Antares Metals Limited (AM5) ORDINARY FULLY PAID |
Materials |
$4 |
Extensional Targets Confirmed by Assays at Surprise
|
21 Jul 2025 9:16AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
AM5 - Price-sensitive ASX Announcement
Full Release
Key Points
- Confirmation of extensional gold targets at the Surprise prospect within the Mandilla Gold Project.
- Assay results demonstrate high-grade gold mineralisation beyond existing resource boundaries.
- Drilling expanded the known mineralisation footprint both laterally and at depth.
- Significant gold intercepts reported from recent reverse circulation and diamond drilling programs.
- Results support the potential for future resource growth at Surprise.
- Antares Metals will continue systematic drilling to further define new extensional zones.
- Assay results to be incorporated into upcoming resource updates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,247 |
Net Tangible Asset Backing - 18 July 2025
|
21 Jul 2025 9:16AM |
$2.620 |
$2.600 |
fallen by
0.76%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$4 |
Proposed issue of securities - RNX
|
21 Jul 2025 9:16AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$4 |
Equity Raising of up to $2,290,000
|
21 Jul 2025 9:16AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
RNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renegade Exploration Limited (RNX) is undertaking an equity raising of up to $2,290,000.
- The raising is via a non-renounceable pro-rata entitlement offer to eligible shareholders.
- Shareholders are offered new shares at a specified issue price, details of which are outlined in the document.
- Funds raised will be used primarily for exploration activities and general working capital.
- The Board believes the capital raising is essential for ongoing operations and future growth.
- Risks and benefits of the entitlement offer are discussed for potential participants.
- Timetable for the offer, including opening and closing dates, is provided.
- Eligibility criteria for shareholders and application instructions are detailed.
- Directors’ support and intentions regarding the offer are disclosed.
- The document emphasizes the importance of reading the entire offer booklet before making investment decisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$345 |
Update - Notification of buy-back - PE1
|
21 Jul 2025 9:15AM |
$1.250 |
$1.250 |
fallen by
0%
|
|
| Eclipse Metals Ltd (EPM) ORDINARY FULLY PAID |
Energy |
$60 |
Investor Presentation
|
21 Jul 2025 9:15AM |
$0.019 |
$0.020 |
risen by
5.26%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$111 |
Trading Halt
|
21 Jul 2025 9:13AM |
$0.285 |
$0.285 |
fallen by
0%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Amplia Therapeutics Limited (ASX: ATX) effective 5 June 2024.
- The trading halt is in relation to a proposed capital raising.
- The halt will remain in place until an announcement is made or trading commences on 7 June 2024.
- Company has confirmed there are no reasons the trading halt should not be granted.
- No additional information required to inform the market at the time of request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$3 |
RBR Positions for Mozambique LNG Growth
|
21 Jul 2025 9:13AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
RBR - Price-sensitive ASX Announcement
Full Release
Key Points
- RBR Group Limited is positioning itself as a workforce solutions provider for Mozambique's LNG projects.
- The company has developed capabilities in recruitment, training, and compliance to meet local content requirements.
- RBR is engaging with international and local contractors involved in the LNG projects.
- The firm has established an operational presence in Mozambique with required licenses and partnerships.
- Services are tailored to support delivery of large, compliant workforces for LNG construction and operations.
- RBR expects multi-year revenue growth opportunities from Mozambique’s LNG sector.
- The company’s strategy focuses on being a trusted partner in workforce management for the region’s LNG industry.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,445 |
BKI Investor Presentation - 2025 Full Year Results
|
21 Jul 2025 9:12AM |
$1.795 |
$1.790 |
fallen by
0.28%
|
|
BKI - Price-sensitive ASX Announcement
Full Release
Key Points
- BKI delivered another year of positive investment returns and upheld its dividend policy.
- The portfolio is concentrated in high-quality Australian listed companies with a bias towards income-producing stocks.
- The company maintained a low-cost structure and continued disciplined, long-term investment strategies.
- BKI outperformed relevant indices over several timeframes, reinforcing its track record.
- Dividend growth was maintained, reflecting resilience and the company’s income focus.
- The management team actively managed capital and took a cautious approach amid market volatility.
- Risk management and governance remain core priorities for the Board and management.
- Sector allocations and top ten holdings are regularly reviewed to ensure alignment with strategy.
- The outlook for the next financial year is cautiously optimistic, emphasizing income and capital preservation for shareholders.
- BKI remains committed to providing shareholders with a stable income stream backed by a high-quality, diversified portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$19 |
Proposed issue of securities - REE
|
21 Jul 2025 9:11AM |
$0.027 |
$0.021 |
fallen by
22.22%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$19 |
Proposed issue of securities - REE
|
21 Jul 2025 9:11AM |
$0.027 |
$0.021 |
fallen by
22.22%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$19 |
RareX Raises $2 Million
|
21 Jul 2025 9:11AM |
$0.027 |
$0.021 |
fallen by
22.22%
|
|
REE - Price-sensitive ASX Announcement
Full Release
Key Points
- RareX Limited successfully raised $2 million via a share placement.
- Shares were issued at $0.017 each, at a discount to the market price.
- Funds will be used mainly for developing the Cummins Range Rare Earths Project in Western Australia.
- The placement attracted support from new and existing institutional and sophisticated investors.
- Proceeds will also be allocated to working capital and general corporate purposes.
- The Cummins Range project is a key strategic asset for rare earth elements (REE) and phosphate.
- Company management expressed strong investor support and commitment to project advancement.
- Capital raising will enable RareX to pursue exploration and project studies for Cummins Range.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,445 |
BKI Announces 2025 Full Year Results
|
21 Jul 2025 9:11AM |
$1.795 |
$1.790 |
fallen by
0.28%
|
|
BKI - Price-sensitive ASX Announcement
Full Release
Key Points
- BKI achieved growth in net tangible assets per share during the year.
- Steady dividend income was distributed to shareholders.
- The investment strategy remained focused on high-quality Australian listed securities.
- Disciplined portfolio management and diversification were maintained.
- Risk management practices were reinforced amid market volatility.
- BKI retained a strong balance sheet and sound liquidity position.
- The Board provided updates on corporate governance and activities.
- The economic environment, including interest rates, was discussed.
- Shareholder engagement was prioritized throughout the year.
- Sustainability and ESG initiatives were highlighted.
- The outlook for the coming year is cautiously optimistic, with a continued focus on delivering sustainable returns.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$39 |
Update - Notification of buy-back - MEC
|
21 Jul 2025 9:09AM |
$1.140 |
$1.145 |
risen by
0.44%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,445 |
BKI 2025 Corporate Governance Statement
|
21 Jul 2025 9:09AM |
$1.795 |
$1.790 |
fallen by
0.28%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,445 |
BKI Appendix 4G for the year ended 30 June 2025
|
21 Jul 2025 9:09AM |
$1.795 |
$1.790 |
fallen by
0.28%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
